GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
GAMMAGARD LIQUID is an established intravenous immune globulin (IVIG) therapy for adults with CIDP. GAMMAGARD LIQUID may help patients manage some CIDP symptoms, such as neuromuscular disability and impairment.
The European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) guidelines strongly recommend IVIG as a treatment option for CIDP.
GAMMAGARD LIQUID is a ready-to-use liquid medicine that contains immune globulin (IG). People with CIDP have a rare autoimmune disease that causes your immune system to attack your nerves, leading to muscle weakness and numbness. IG is thought to reduce the damage to the nerves and assist in defending nerves from harm.
Not all IGs are the same. GAMMAGARD LIQUID has a different formula.
No added
sugars, sucrose
or glucose
No added
sodium
No added
preservatives
No proline
stabilizers
GAMMAGARD LIQUID packaging is not made with natural rubber latex. GAMMAGARD LIQUID is also stabilized and buffered with glycine.
Talk to your doctor about a SubQ IG therapy with extended dosing schedule for appropriate patients.